Noortje van Herwaarden
Overview
Explore the profile of Noortje van Herwaarden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kruis I, Kumari J, van der Heijden A, Weijn A, Vree Egberts W, Peeters I, et al.
Rheumatol Adv Pract
. 2025 Feb;
9(1):rkaf010.
PMID: 39959134
Objectives: ACPAs play an important role in the classification of RA and can be detected by serological tests. Several ACPA detection assays are available for clinical use, which are all...
2.
Muskens W, Dees M, Stikkelbroeck M, van Herwaarden N, Kramers C
Ned Tijdschr Geneeskd
. 2024 Oct;
168.
PMID: 39382356
Corticosteroids are often administered locally to prevent systemic exposure and side effects. It is not well known that all forms of locally administered corticosteroids can have systemic side effects. Because...
3.
Wientjes M, van Huissteden J, van Herwaarden N, Verhoef L, den Broeder A
Clin Exp Rheumatol
. 2024 Jul;
42(11):2215-2220.
PMID: 39051162
Objectives: To determine the effects of dose reduction of rituximab (RTX) on rheumatoid arthritis (RA) disease activity in clinical practice. Methods: Retrospective cohort study of RA patients using RTX, in...
4.
Peeters I, Veenstra F, Wanten S, Vriezekolk J, van den Ende C, den Broeder A, et al.
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(11):1574-1583.
PMID: 38924379
Objective: Long-term gout management is based on reducing serum urate by using urate-lowering therapy (ULT). A lifelong treat-to-target approach is advocated, although a ULT (taper to) stop attempt can be...
5.
den Broeder N, Bolhuis T, van Herwaarden N, Bergstra S, Bouman C, van den Hoogen F, et al.
Rheumatology (Oxford)
. 2024 Jun;
64(3):1464-1468.
PMID: 38867707
Objectives: The Simple Erosion Narrowing Score (SENS) is a simplification of the Sharp/van der Heijde score (SHS). Previous studies found SENS and SHS to have very similar measurement properties, but...
6.
van der Togt C, den Broeder N, Boonstra M, van der Maas A, den Broeder A, van Herwaarden N
Rheumatology (Oxford)
. 2024 Feb;
64(2):533-540.
PMID: 38346712
Objective: The objective of this study was to investigate the safety and effectiveness of disease activity-guided dose optimization of TNF inhibitors in RA over 10 years. Methods: The study involved...
7.
Ulijn E, den Broeder N, Ten Cate D, van Overdijk K, Demirel H, Landewe R, et al.
Arthritis Care Res (Hoboken)
. 2023 Nov;
76(4):497-502.
PMID: 37933435
Objective: Current recommendations suggest that patients with newly presenting arthritis suspected of rheumatoid arthritis (RA) should undergo routine radiographs of hands and feet (X-HF) as the presence of RA-associated erosions...
8.
Popa C, Opdam M, den Broeder N, van Ballegooijen H, Mulder K, van de Wiel K, et al.
Rheumatology (Oxford)
. 2023 Oct;
63(8):2142-2146.
PMID: 37796830
Objective: Caution has been advocated recently when using Janus kinase inhibitors (JAKi) in rheumatoid arthritis (RA) patients with an unfavourable cardiovascular risk profile. We aimed to compare the incidences in...
9.
Kerstens F, Spijkers K, Wolthuis D, Boers M, van Herwaarden N, Ten Cate D
Rheumatology (Oxford)
. 2023 Jul;
63(1):e15-e16.
PMID: 37421380
No abstract available.
10.
Veenstra F, Vriezekolk J, van den Bemt B, Schers H, Sloot B, van den Ende C, et al.
Rheumatol Adv Pract
. 2023 Apr;
7(2):rkad033.
PMID: 37113501
Objective: To describe beliefs of physicians and patients in primary and secondary care about urate-lowering therapy (ULT), to examine differences in physicians' medication beliefs and to examine the association of...